These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18081619)

  • 1. Brief assessment of cognition in schizophrenia: validation of the Japanese version.
    Kaneda Y; Sumiyoshi T; Keefe R; Ishimoto Y; Numata S; Ohmori T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):602-9. PubMed ID: 18081619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of clinical factors influencing cognitive function in Japanese schizophrenia.
    Kishi T; Moriwaki M; Kawashima K; Okochi T; Fukuo Y; Kitajima T; Furukawa O; Naitoh H; Fujita K; Iwata N
    Neurosci Res; 2010 Apr; 66(4):340-4. PubMed ID: 20025912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates associated with cognitive dysfunction in people with schizophrenia.
    Tanaka T; Tomotake M; Ueoka Y; Kaneda Y; Taniguchi K; Nakataki M; Numata S; Tayoshi S; Yamauchi K; Sumitani S; Ohmori T; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):491-8. PubMed ID: 23066766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Persian version of the brief assessment of cognition in schizophrenia in patients with schizophrenia and healthy controls.
    Mazhari S; Parvaresh N; Eslami Shahrbabaki M; Sadeghi MM; Nakhaee N; Keefe RS
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):160-6. PubMed ID: 24552637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement and Treatment Research toImprove Cognition in Schizophrenia Consensus Cognitive Battery: validation of the Japanese version.
    Kaneda Y; Ohmori T; Okahisa Y; Sumiyoshi T; Pu S; Ueoka Y; Takaki M; Nakagome K; Sora I
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):182-8. PubMed ID: 23581870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients.
    Bralet MC; Falissard B; Neveu X; Lucas-Ross M; Eskenazi AM; Keefe RS
    Eur Psychiatry; 2007 Sep; 22(6):365-70. PubMed ID: 17434715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
    Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    J Psychiatr Res; 2012 Jun; 46(6):757-61. PubMed ID: 22464338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.
    Dickinson D; Ramsey ME; Gold JM
    Arch Gen Psychiatry; 2007 May; 64(5):532-42. PubMed ID: 17485605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia].
    Kaneda Y; Ueoka Y; Sumiyoshi T; Yasui-Furukori N; Ito T; Higuchi Y; Suzuki M; Ohmori T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):259-62. PubMed ID: 22256616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizotypal disorder and schizophrenia: a profile analysis of neuropsychological functioning in Japanese patients.
    Matsui M; Yuuki H; Kato K; Takeuchi A; Nishiyama S; Bilker WB; Kurachi M
    J Int Neuropsychol Soc; 2007 Jul; 13(4):672-82. PubMed ID: 17521484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypertension on attention, memory, and executive function in older adults.
    Saxby BK; Harrington F; McKeith IG; Wesnes K; Ford GA
    Health Psychol; 2003 Nov; 22(6):587-91. PubMed ID: 14640855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.
    Keefe RS; Poe M; Walker TM; Harvey PD
    J Clin Exp Neuropsychol; 2006 Feb; 28(2):260-9. PubMed ID: 16484097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and cognitive dysfunction in people with schizophrenia.
    Ueoka Y; Tomotake M; Tanaka T; Kaneda Y; Taniguchi K; Nakataki M; Numata S; Tayoshi S; Yamauchi K; Sumitani S; Ohmori T; Ueno S; Ohmori T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):53-9. PubMed ID: 20804809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal factor analytic study of children's neurocognitive abilities.
    Townes BD; Rosenbaum G; Martin MD; Martins IP; Luis H; Bernardo M
    Int J Neurosci; 2008 Jul; 118(7):1009-23. PubMed ID: 18569157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the executive functions in schizophrenia: the voluntary allocation of effort.
    van Beilen M; van Zomeren EH; van den Bosch RJ; Withaar FK; Bouma A
    J Psychiatr Res; 2005 Nov; 39(6):585-93. PubMed ID: 16157161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verbal memory and verbal fluency in adolescents with schizophrenia spectrum disorders.
    Landrø NI; Ueland T
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):653-61. PubMed ID: 19068001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.
    Donohoe G; Morris DW; Clarke S; McGhee KA; Schwaiger S; Nangle JM; Garavan H; Robertson IH; Gill M; Corvin A
    Neuropsychologia; 2007 Jan; 45(2):454-8. PubMed ID: 16930638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.